1. Home
  2. SLAB vs CRSP Comparison

SLAB vs CRSP Comparison

Compare SLAB & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLAB
  • CRSP
  • Stock Information
  • Founded
  • SLAB 1996
  • CRSP 2013
  • Country
  • SLAB United States
  • CRSP Switzerland
  • Employees
  • SLAB N/A
  • CRSP N/A
  • Industry
  • SLAB Semiconductors
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SLAB Technology
  • CRSP Health Care
  • Exchange
  • SLAB Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • SLAB 4.8B
  • CRSP 4.2B
  • IPO Year
  • SLAB 2000
  • CRSP 2016
  • Fundamental
  • Price
  • SLAB $142.51
  • CRSP $56.62
  • Analyst Decision
  • SLAB Buy
  • CRSP Buy
  • Analyst Count
  • SLAB 9
  • CRSP 16
  • Target Price
  • SLAB $132.44
  • CRSP $71.20
  • AVG Volume (30 Days)
  • SLAB 467.4K
  • CRSP 3.7M
  • Earning Date
  • SLAB 07-23-2025
  • CRSP 08-04-2025
  • Dividend Yield
  • SLAB N/A
  • CRSP N/A
  • EPS Growth
  • SLAB N/A
  • CRSP N/A
  • EPS
  • SLAB N/A
  • CRSP N/A
  • Revenue
  • SLAB $655,725,000.00
  • CRSP $37,675,000.00
  • Revenue This Year
  • SLAB $37.27
  • CRSP $30.25
  • Revenue Next Year
  • SLAB $19.90
  • CRSP $268.62
  • P/E Ratio
  • SLAB N/A
  • CRSP N/A
  • Revenue Growth
  • SLAB 2.16
  • CRSP N/A
  • 52 Week Low
  • SLAB $82.82
  • CRSP $30.04
  • 52 Week High
  • SLAB $160.00
  • CRSP $63.68
  • Technical
  • Relative Strength Index (RSI)
  • SLAB 53.98
  • CRSP 71.90
  • Support Level
  • SLAB $139.11
  • CRSP $50.26
  • Resistance Level
  • SLAB $145.74
  • CRSP $62.00
  • Average True Range (ATR)
  • SLAB 4.45
  • CRSP 2.97
  • MACD
  • SLAB -1.58
  • CRSP 0.93
  • Stochastic Oscillator
  • SLAB 23.71
  • CRSP 71.76

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: